This is the authors' abstract. We don't add key points for this paper.
Vigorous control of withdrawal and PTSD-related arousal symptoms should be sought during detoxification of patients with comorbid PTSD and substance use disorders. Inclusion of patients with comorbid PTSD and substance use disorders in neurobiologic research and in clinical trials will be critical for development of effective treatments for this severely symptomatic patient population.
No takes yet. Share an insight, caveat, or question.
Jacobsen et al. (2001) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: